V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER ISSN 1068-1760
I
N
Vol. 39 No.6 • 10/2022
T
E
Testing Breakthrough on Effects of Long COVID
W
ith no current framework or diagnostic tools, patients suffering from the effects of COVID-19 and long COVID-19 present general practitioners with a major health challenge. Now, a new discovery will aid the diagnosis of debilitating symptoms
Cont’d on page 20
R
N
A
T
I
O
DAILY CLINICAL LAB NEWS
®
N
AI-Enabled Diagnostic Solutions Improve Treatment of Breast and Colorectal Cancers
T
wo first-in-class rapid, affordable AI-based diagnostic solutions that are designed to improve outcomes for patients with breast cancer and colorectal cancer have been approved for use in Europe. By using AI to analyze digital
pathology images, they are designed to help clinicians make precision medicine – diagnostic and treatment based on a patient’s individual characteristics – more accessible to more patients at an earlier stage of their disease.
Cont’d on page 13
New Diagnostic Platform, As Sensitive As PCR, LAMP or LFT, But Much Faster
A
L
New Guidelines for POC Fertility Testing
P
oint-of-care tests are clinical tests that are performed near the patient instead of in a central lab. Due to their convenience and rapid turnaround times, these tests can help patients to get treatment much faster than traditional tests. As a result, the use of pointof-care testing has risen steadily in all areas of healthcare. In the fertility and reproductive health fields in particular, it is now used Cont’d on page 14
Cord Blood IgE Levels Tied to Allergy, Asthma
T
A
he rising prevalence of allergic diseases worldwide represents an important health problem. Early identification of children at high risk of allergic diseases could be helpful for physicians to recommend preventive measures and apply early interventions. Cord blood immunoglobulin E (IgE) has been considered as a potential marker for years due to
breakthrough viral testing method known as RTF-EXPAR, matches current gold standard tests in accuracy, while faster, simpler and able to detect lower levels. See article on page 7
Cont’d on page 18 V
I
S
I
T
LINKXPRESS COM
R E A D E R
S E R V I C E
®
P O R T A L
Blood-Based Liver Test Could Replace Invasive Biopsies
A
pproximately one in four people worldwide, or approximately two billion people, have non-alcoholic fatty liver disease (NAFLD) and therefore are at risk of developing nonalcoholic steatohepatitis (NASH). NASH is the most severe form of NAFLD, a silent disease
Renew/Start your Free Subscription Access Interactive Digital Magazine Instant Online Product Information: Identify LinkXpress codes of 1 interest as you read magazine
Cont’d on page 4
®
on LinkXpress.com 2 toClick reach reader service portal
3
Mark code(s) of interest on LinkXpress ® inquiry matrix
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
E
Microchip Imaging Cytometry Improves Laboratory Testing
conomic globalization and the aging population of many countries in the world generate an enormous need for rapid and cost-effective point-of-need laboratory tests. Over the past two years, the entire world has been tackling challenges from the COVID-19
pandemic. The general population in many countries are routinely taking nucleic acid tests and/or rapid antigen tests for screening purposes. Healthcare workers are in need of more economical, and easy-to-use diagnostic testing tools to support their healthcare pracCont’d on page 17
INSIDE Clinical News. . . . . 4 IFCC News. . . . . . 21 Product News .. 6-20 Industry News .. . 25 Events Calendar. . 26 PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<